AB002. OS01.02. A phase ii study of chemotherapy concurrent …
Emerging
0
Citations0
Refs2017
Year
Search Works
Work Details
- DOI 10.21037/med.2017.ab002
- OpenAlex ID W2767955259
- Type Conference-abstract
- Language EN
- Published 01 Jan 2017
- Volume 1
- Pages AB002
- Source Mediastinum
- Publisher AME Publishing Company
- Countries 1
- Institutions 1
- Added 17 Nov 2017
- Updated 01 Oct 2026
External Links
MENU
0
AB002. OS01.02. A phase ii study of chemotherapy concurrent with radiotherapy in patients with unresectable advanced thymic tumors
Conference-abstract 2017 EN Hybrid
Background: Thymic malignancies are rare, and treatment options for unresectable thymic epithelial tumors (TET) are limited. We conducted a prospective phase II study of cisplatin plus etoposide concurrent with intensive modulated radiotherapy (IMRT) in patients with unresectable stage III or IV thymic epithelial tumors, to determine the efficacy and tolerability of the combination therapy. Method…
0
Citations
0
References
7
Authors
0.00
FWCI
Topics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
7 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Kailiang Wu | Fudan University Shanghai Canc… (CN) | |
| 2 | Xing-Wen Fan | Fudan University Shanghai Canc… (CN) | — |
| 3 | Hong-Bing Wang | Fudan University Shanghai Canc… (CN) | — |
| 4 | Yang Yu | Fudan University Shanghai Canc… (CN) | |
| 5 | Liyi Xie | Fudan University Shanghai Canc… (CN) | |
| 6 | Ling Li | Fudan University Shanghai Canc… (CN) | |
| 7 | Yin Xu | Fudan University Shanghai Canc… (CN) |
Related Works
10Data: OpenAlex